(Q64727454)

English

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

clinical trial

Statements

A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients With Relapsed or Refractory Follicular Lymphoma (English)
0 references
January 2002
0 references
September 2002
0 references
42
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit